Filing Details

Accession Number:
0000950170-24-001035
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-01-03 16:54:23
Reporting Period:
2023-12-29
Accepted Time:
2024-01-03 16:54:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1785173 89Bio Inc. ETNB () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1423327 Rohan Palekar C/O 89Bio, Inc.
142 Sansome Street, 2Nd Floor
San Francisco CA 94104
Chief Executive Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-12-29 50,000 $1.93 351,225 No 4 M Direct
Common Stock Disposition 2023-12-29 50,000 $11.20 301,225 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2023-12-29 50,000 $0.00 50,000 $1.93
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
145,231 2028-11-09 No 4 M Direct
Footnotes
  1. Includes an aggregate of 275 shares acquired by the Reporting Person under the Issuer's 2019 Employee Stock Purchase Plan on December 31, 2023.
  2. This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on July 5, 2023.
  3. The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $11.035 to $11.33. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
  4. This option is vested in full.